Signition LP’s NxStage Medical Inc. NXTM Stock Holding History

Signition LP’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-32,272	Closed	-$782K	–	200
2017 Q4	$782K	Buy	+32,272	New	+$850K	1.01%	23

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Signition LP's NXTM Position: Q1 2018 in Review

Signition LP sold out of NxStage Medical Inc. (NXTM) in Q1 2018, closing a stake of 32,272 shares — an estimated $782K sold.

Signition LP first reported a position in NXTM in Q4 2017 and held it in 1 quarter. The position peaked at $782K in Q4 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q1 2018.

Signition LP reported no remaining NxStage Medical Inc. position as of Q1 2018 after selling out during the quarter.
Signition LP sold 32,272 NxStage Medical Inc. shares in Q1 2018, an estimated $782K.
Signition LP first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 1 quarter.
Signition LP's NxStage Medical Inc. position peaked at $782K in Q4 2017.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2018.

Based on Signition LP's 13F filing for Q1 2018, filed 14 May 2018.